Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane-Reference-Cited by-同舟云学术

Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane

Published:2022-06 Issue: Volume:145 Page:246-259
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Liang Bin,Jiang Dawei,Pan Luqi,Xiong Fang,Feng Shuya,Wu Shenghao,Ye Haige,Yu Zhijie,Shi Changcan,Gao Shenmeng

Funder

China Postdoctoral Science Foundation

Natural Science Foundation of Zhejiang Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference45 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

3. Leukemia stem cells;Testa;Ann. Hematol.,2011

4. Context, context, context: new gene programs linked to bad behavior in MLL-AF9-initiated leukemia;Watanabe;Cancer Cell,2016

5. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model;Montesinos;Haematologica,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current research trends of nanomedicines;Acta Pharmaceutica Sinica B;2023-11

2. Idarubicin and IR780 co-loaded PEG-b-PTMC nanoparticle for non-Hodgkin’s lymphoma therapy by photothermal/photodynamic strategy;Materials & Design;2023-06

3. Mitochondrial-targeted nanoparticles: Delivery and therapeutic agents in cancer;Drug Discovery Today;2023-03

4. Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy;Pharmaceutics;2022-12-28